Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.

Dechuang JiaoJingyang ZhangJiujun ZhuXuhui GuoYue YangHui XiaoZhenzhen Liu

Published in: BMC cancer (2021)

Patients with IBC and T4-non-IBC had a similar BCSS in the era of modern systemic treatment. In IBC patients, the HR-/HER2+ subtype is associated with a better outcome, and HR-/HER2- subtype is associated with poorer outcomes as compared to the T4-non-IBC patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
squamous cell carcinoma
peritoneal dialysis
prognostic factors
oxidative stress
type diabetes
skeletal muscle
drug induced
data analysis